Key Takeaways
- • Sofinnova Partners, a Paris, London and Milan-based European life-sciences venture capital firm managing over €4 billion in assets, promoted Javier Nunez-Vicandi to Partner, joining Edward Kliphuis and Simon Turner in its Digital Medicine strategy.
- • Nunez-Vicandi co-led the build of Sofia, Sofinnova's proprietary AI platform that supports investment decisions and scientific analysis, and helped lead the firm's collaborations with AWS and NVIDIA.
- • He holds observer seats on the boards of Latent Labs, Bioptimus, Cure51, Deepc and Kiro, and recently led an investment that remains in stealth.
- • The promotion underscores Sofinnova's growing focus on healthtech and techbio, which the firm defines as technology applied to healthcare delivery and AI-driven biological research and drug discovery.
Summary
Sofinnova Partners, a leading European venture capital firm in life sciences, has promoted Javier Nunez-Vicandi to Partner, according to a BUSINESS WIRE announcement. He joins Edward Kliphuis and Simon Turner in the firm's Digital Medicine strategy, which invests in startups working at the intersection of biology, data and AI. Sofinnova was founded in 1972, has backed more than 500 companies and manages over €4 billion in assets.
Since joining Sofinnova in 2022, Nunez-Vicandi has played a key role in developing the Digital Medicine strategy and the firm's broader AI efforts, helping shape key AI investment theses. He is an observer on the boards of Latent Labs, Bioptimus, Cure51, Deepc and Kiro, and has recently led an investment that remains in stealth. He co-led the project that created Sofia, Sofinnova's proprietary AI platform supporting investments and scientific analysis, and helped lead the firm's collaborations with AWS and NVIDIA.
Chairman and Managing Partner Antoine Papiernik said Nunez-Vicandi "combines clinical experience, scientific rigor and a deep understanding of technology," and described him as a trusted investor and important contributor to the Digital Medicine strategy. Nunez-Vicandi said his clinical work showed him how critical it is to get effective treatments to patients who need them, and described supporting founders who use AI to advance healthcare as a privilege.
Before Sofinnova, Nunez-Vicandi was the first employee at Heal Capital, an early-stage healthtech venture fund, where he helped grow the firm from launch to 12 investments. He previously worked as an analyst at M Ventures, focusing on data-driven healthcare, biotechnology and automation. He began his career practicing medicine at Oxford University Hospitals NHS Foundation Trust, including roles at the National Spinal Injuries Centre and Churchill Hospital. He holds an MPhil with distinction from the University of Cambridge and an MBBS from Newcastle University.
Since joining Sofinnova in 2022, Nunez-Vicandi has played a key role in developing the Digital Medicine strategy and the firm's broader AI efforts, helping shape key AI investment theses. He is an observer on the boards of Latent Labs, Bioptimus, Cure51, Deepc and Kiro, and has recently led an investment that remains in stealth. He co-led the project that created Sofia, Sofinnova's proprietary AI platform supporting investments and scientific analysis, and helped lead the firm's collaborations with AWS and NVIDIA.
Chairman and Managing Partner Antoine Papiernik said Nunez-Vicandi "combines clinical experience, scientific rigor and a deep understanding of technology," and described him as a trusted investor and important contributor to the Digital Medicine strategy. Nunez-Vicandi said his clinical work showed him how critical it is to get effective treatments to patients who need them, and described supporting founders who use AI to advance healthcare as a privilege.
Before Sofinnova, Nunez-Vicandi was the first employee at Heal Capital, an early-stage healthtech venture fund, where he helped grow the firm from launch to 12 investments. He previously worked as an analyst at M Ventures, focusing on data-driven healthcare, biotechnology and automation. He began his career practicing medicine at Oxford University Hospitals NHS Foundation Trust, including roles at the National Spinal Injuries Centre and Churchill Hospital. He holds an MPhil with distinction from the University of Cambridge and an MBBS from Newcastle University.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.